National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global Exocrine Pancreatic Insufficiency Market Size, Status and Forecast 2025

Global Exocrine Pancreatic Insufficiency Market Size, Status and Forecast 2025

Goods_sn:huishizhe-gz6

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global Exocrine Pancreatic Insufficiency Market Size, Status and Forecast 2025

Hard Copy: 3300 USD
PDF Copy (single user): 3300 USD
Enterprise wide License: 6600 USD
Pages: 99
Tables and Figures: 102
Published Date: June 2018
Publisher: QYR Medical Care Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

This report studies the global Exocrine Pancreatic Insufficiency market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Exocrine Pancreatic Insufficiency market by companies, region, type and end-use industry.

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.
EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cells, which generates the digestive enzymes. EPI disturbs the normal growth, life expectancy and immune response. Diarrhoea, Steatorrhea, fatigue and weight loss are the key symptoms of EPI.
In 2017, the global Exocrine Pancreatic Insufficiency market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global top players, covered
    Axcan Pharma
    Aptalis Pharma
    Eli Lilly
    Cilian
    Nordmark Arzneimittel
    Laboratoires Mayoly Spindler
    ...

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

Market segment by Type, the product can be split into
    Nutritional management
    Pancreatic enzyme replacement therapy (PERT)
    Life style modifications approach

Market segment by Application, split into
    Nutritional management
    Pancreatic enzyme replacement therapy (PERT)
    Life style modifications approach

The study objectives of this report are:
    To study and forecast the market size of Exocrine Pancreatic Insufficiency in global market.
    To analyze the global key players, SWOT analysis, value and global market share for top players.
    To define, describe and forecast the market by type, end use and region.
    To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
    To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Exocrine Pancreatic Insufficiency are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Exocrine Pancreatic Insufficiency Manufacturers
Exocrine Pancreatic Insufficiency Distributors/Traders/Wholesalers
Exocrine Pancreatic Insufficiency Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Exocrine Pancreatic Insufficiency market, by end-use.
Detailed analysis and profiles of additional market players.


Table of Contents

Global Exocrine Pancreatic Insufficiency Market Size, Status and Forecast 2025
1 Industry Overview of Exocrine Pancreatic Insufficiency
    1.1 Exocrine Pancreatic Insufficiency Market Overview
        1.1.1 Exocrine Pancreatic Insufficiency Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Exocrine Pancreatic Insufficiency Market Size and Analysis by Regions (2013-2018)
        1.2.1 United States
        1.2.2 Europe
        1.2.3 China
        1.2.4 Japan
        1.2.5 Southeast Asia
        1.2.6 India
    1.3 Exocrine Pancreatic Insufficiency Market by Type
        1.3.1 Nutritional management
        1.3.2 Pancreatic enzyme replacement therapy (PERT)
        1.3.3 Life style modifications approach
    1.4 Exocrine Pancreatic Insufficiency Market by End Users/Application
        1.4.1 Nutritional management
        1.4.2 Pancreatic enzyme replacement therapy (PERT)
        1.4.3 Life style modifications approach

2 Global Exocrine Pancreatic Insufficiency Competition Analysis by Players
    2.1 Exocrine Pancreatic Insufficiency Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Axcan Pharma
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Exocrine Pancreatic Insufficiency Revenue (Million USD) (2013-2018)
    3.2 Aptalis Pharma
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Exocrine Pancreatic Insufficiency Revenue (Million USD) (2013-2018)
    3.3 Eli Lilly
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Exocrine Pancreatic Insufficiency Revenue (Million USD) (2013-2018)
    3.4 Cilian
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Exocrine Pancreatic Insufficiency Revenue (Million USD) (2013-2018)
    3.5 Nordmark Arzneimittel
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Exocrine Pancreatic Insufficiency Revenue (Million USD) (2013-2018)
    3.6 Laboratoires Mayoly Spindler
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Exocrine Pancreatic Insufficiency Revenue (Million USD) (2013-2018)

4 Global Exocrine Pancreatic Insufficiency Market Size by Type and Application (2013-2018)
    4.1 Global Exocrine Pancreatic Insufficiency Market Size by Type (2013-2018)
    4.2 Global Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)
    4.3 Potential Application of Exocrine Pancreatic Insufficiency in Future
    4.4 Top Consumer/End Users of Exocrine Pancreatic Insufficiency

5 United States Exocrine Pancreatic Insufficiency Development Status and Outlook
    5.1 United States Exocrine Pancreatic Insufficiency Market Size (2013-2018)
    5.2 United States Exocrine Pancreatic Insufficiency Market Size and Market Share by Players (2013-2018)
    5.3 United States Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)

6 Europe Exocrine Pancreatic Insufficiency Development Status and Outlook
    6.1 Europe Exocrine Pancreatic Insufficiency Market Size (2013-2018)
    6.2 Europe Exocrine Pancreatic Insufficiency Market Size and Market Share by Players (2013-2018)
    6.3 Europe Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)

7 China Exocrine Pancreatic Insufficiency Development Status and Outlook
    7.1 China Exocrine Pancreatic Insufficiency Market Size (2013-2018)
    7.2 China Exocrine Pancreatic Insufficiency Market Size and Market Share by Players (2013-2018)
    7.3 China Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)

8 Japan Exocrine Pancreatic Insufficiency Development Status and Outlook
    8.1 Japan Exocrine Pancreatic Insufficiency Market Size (2013-2018)
    8.2 Japan Exocrine Pancreatic Insufficiency Market Size and Market Share by Players (2013-2018)
    8.3 Japan Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)

9 Southeast Asia Exocrine Pancreatic Insufficiency Development Status and Outlook
    9.1 Southeast Asia Exocrine Pancreatic Insufficiency Market Size (2013-2018)
    9.2 Southeast Asia Exocrine Pancreatic Insufficiency Market Size and Market Share by Players (2013-2018)
    9.3 Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)

10 India Exocrine Pancreatic Insufficiency Development Status and Outlook
    10.1 India Exocrine Pancreatic Insufficiency Market Size (2013-2018)
    10.2 India Exocrine Pancreatic Insufficiency Market Size and Market Share by Players (2013-2018)
    10.3 India Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Exocrine Pancreatic Insufficiency Market Size (Value) by Regions (2018-2025)
        11.1.1 United States Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2018-2025)
        11.1.2 Europe Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2018-2025)
        11.1.3 China Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2018-2025)
        11.1.4 Japan Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2018-2025)
        11.1.5 Southeast Asia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2018-2025)
        11.1.6 India Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2018-2025)
    11.2 Global Exocrine Pancreatic Insufficiency Market Size (Value) by Type (2018-2025)
    11.3 Global Exocrine Pancreatic Insufficiency Market Size by Application (2018-2025)

12 Exocrine Pancreatic Insufficiency Market Dynamics
    12.1 Exocrine Pancreatic Insufficiency Market Opportunities
    12.2 Exocrine Pancreatic Insufficiency Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Exocrine Pancreatic Insufficiency Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Exocrine Pancreatic Insufficiency Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Global Exocrine Pancreatic Insufficiency Market Size (Million USD) Status and Outlook (2013-2018)
    Table Global Exocrine Pancreatic Insufficiency Revenue (Million USD) Comparison by Regions (2013-2018)
    Figure Global Exocrine Pancreatic Insufficiency Market Share by Regions (2013-2018)
    Figure United States Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Europe Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Japan Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Southeast Asia Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure India Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Global Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
    Figure Global Exocrine Pancreatic Insufficiency Revenue Market Share by Type in 2017
    Figure Nutritional management Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Pancreatic enzyme replacement therapy (PERT) Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Life style modifications approach Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Exocrine Pancreatic Insufficiency Market Share by Application in 2017
    Figure Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate in Nutritional management (2013-2018)
    Figure Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate in Pancreatic enzyme replacement therapy (PERT) (2013-2018)
    Figure Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate in Life style modifications approach (2013-2018)
    Table Exocrine Pancreatic Insufficiency Market Size (Million USD) by Players (2013-2018)
    Figure Exocrine Pancreatic Insufficiency Market Size Share by Players in 2013
    Figure Exocrine Pancreatic Insufficiency Market Size Share by Players in 2017
    Table Axcan Pharma Basic Information List
    Table Exocrine Pancreatic Insufficiency Business Revenue (Million USD) of Axcan Pharma (2013-2018)
    Figure Axcan Pharma Exocrine Pancreatic Insufficiency Business Revenue Market Share (2013-2018)
    Table Aptalis Pharma Basic Information List
    Table Exocrine Pancreatic Insufficiency Business Revenue (Million USD) of Aptalis Pharma (2013-2018)
    Figure Aptalis Pharma Exocrine Pancreatic Insufficiency Business Revenue Market Share (2013-2018)
    Table Eli Lilly Basic Information List
    Table Exocrine Pancreatic Insufficiency Business Revenue (Million USD) of Eli Lilly (2013-2018)
    Figure Eli Lilly Exocrine Pancreatic Insufficiency Business Revenue Market Share (2013-2018)
    Table Cilian Basic Information List
    Table Exocrine Pancreatic Insufficiency Business Revenue (Million USD) of Cilian (2013-2018)
    Figure Cilian Exocrine Pancreatic Insufficiency Business Revenue Market Share (2013-2018)
    Table Nordmark Arzneimittel Basic Information List
    Table Exocrine Pancreatic Insufficiency Business Revenue (Million USD) of Nordmark Arzneimittel (2013-2018)
    Figure Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Business Revenue Market Share (2013-2018)
    Table Laboratoires Mayoly Spindler Basic Information List
    Table Exocrine Pancreatic Insufficiency Business Revenue (Million USD) of Laboratoires Mayoly Spindler (2013-2018)
    Figure Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Business Revenue Market Share (2013-2018)
    Table Global Exocrine Pancreatic Insufficiency Market Size (Million USD) by Product (2013-2018)
    Figure Global Exocrine Pancreatic Insufficiency Revenue Market Share (%) by Product (2013-2018)
    Figure Global Exocrine Pancreatic Insufficiency Market Share by Product in 2017
    Table Global Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)
    Figure Global Exocrine Pancreatic Insufficiency Revenue Market Share (%) by Application in 2017
    Table Top Consumer/End Users of Exocrine Pancreatic Insufficiency
    Figure United States Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate (2013-2018)
    Table United States Exocrine Pancreatic Insufficiency Market Size (Million USD) by Players (2013-2018)
    Figure United States Exocrine Pancreatic Insufficiency Market Size Share by Players in 2013
    Figure United States Exocrine Pancreatic Insufficiency Market Size Share by Players in 2017
    Table United States Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)
    Figure United States Exocrine Pancreatic Insufficiency Revenue Market Share (%) by Application (2013-2018)
    Figure United States Exocrine Pancreatic Insufficiency Market Size Share by Application in 2017
    Figure Europe Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate (2013-2018)
    Table Europe Exocrine Pancreatic Insufficiency Market Size (Million USD) by Players (2013-2018)
    Figure Europe Exocrine Pancreatic Insufficiency Market Size Share by Players in 2013
    Figure Europe Exocrine Pancreatic Insufficiency Market Size Share by Players in 2017
    Table Europe Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)
    Figure Europe Exocrine Pancreatic Insufficiency Revenue Market Share (%) by Application (2013-2018)
    Figure Europe Exocrine Pancreatic Insufficiency Market Size Share by Application in 2017
    Figure China Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate (2013-2018)
    Table China Exocrine Pancreatic Insufficiency Market Size (Million USD) by Players (2013-2018)
    Figure China Exocrine Pancreatic Insufficiency Market Size Share by Players in 2013
    Figure China Exocrine Pancreatic Insufficiency Market Size Share by Players in 2017
    Table China Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)
    Figure China Exocrine Pancreatic Insufficiency Revenue Market Share (%) by Application (2013-2018)
    Figure China Exocrine Pancreatic Insufficiency Market Size Share by Application in 2017
    Figure Japan Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate (2013-2018)
    Table Japan Exocrine Pancreatic Insufficiency Market Size (Million USD) by Players (2013-2018)
    Figure Japan Exocrine Pancreatic Insufficiency Market Size Share by Players in 2013
    Figure Japan Exocrine Pancreatic Insufficiency Market Size Share by Players in 2017
    Table Japan Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)
    Figure Japan Exocrine Pancreatic Insufficiency Revenue Market Share (%) by Application (2013-2018)
    Figure Japan Exocrine Pancreatic Insufficiency Market Size Share by Application in 2017
    Figure Southeast Asia Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate (2013-2018)
    Table Southeast Asia Exocrine Pancreatic Insufficiency Market Size (Million USD) by Players (2013-2018)
    Figure Southeast Asia Exocrine Pancreatic Insufficiency Market Size Share by Players in 2013
    Figure Southeast Asia Exocrine Pancreatic Insufficiency Market Size Share by Players in 2017
    Table Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)
    Figure Southeast Asia Exocrine Pancreatic Insufficiency Revenue Market Share (%) by Application (2013-2018)
    Figure Southeast Asia Exocrine Pancreatic Insufficiency Market Size Share by Application in 2017
    Figure India Exocrine Pancreatic Insufficiency Market Size (Million USD) and Growth Rate (2013-2018)
    Table India Exocrine Pancreatic Insufficiency Market Size (Million USD) by Players (2013-2018)
    Figure India Exocrine Pancreatic Insufficiency Market Size Share by Players in 2013
    Figure India Exocrine Pancreatic Insufficiency Market Size Share by Players in 2017
    Table India Exocrine Pancreatic Insufficiency Market Size by Application (2013-2018)
    Figure India Exocrine Pancreatic Insufficiency Revenue Market Share (%) by Application (2013-2018)
    Figure India Exocrine Pancreatic Insufficiency Market Size Share by Application in 2017
    Figure Global Exocrine Pancreatic Insufficiency Market Size and Growth Rate (2018-2025)
    Table Global Exocrine Pancreatic Insufficiency Market Size (Million USD) by Regions (2018-2025)
    Figure Global Exocrine Pancreatic Insufficiency Market Size Share (2018-2025)
    Figure Global Exocrine Pancreatic Insufficiency Market Size Share by Regions in 2025
    Figure United States Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Europe Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Japan Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Southeast Asia Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2018-2025)
    Figure India Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Exocrine Pancreatic Insufficiency Market Size (Million USD) by Type (2018-2025)
    Figure Global Exocrine Pancreatic Insufficiency Market Size Share by Type in 2018
    Figure Global Exocrine Pancreatic Insufficiency Market Size Share by Type in 2025
    Table Global Exocrine Pancreatic Insufficiency Market Size (Million USD) by Application (2018-2025)
    Figure Global Exocrine Pancreatic Insufficiency Market Size (Million USD) by Application in 2018

Request sample If you need any reports sample, just let us know.